Title: 2025-2026 Regular Session SR 140 PN 1129 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1129
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session SR 140 PN 1129 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1129 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.140 Session of 2025 INTRODUCED BY MARTIN, BROWN, SCHWANK, LAUGHLIN, PHILLIPS-HILL, ROBINSON, MASTRIANO, ARGALL, BOSCOLA, TARTAGLIONE, CULVER, BROOKS, FONTANA, J. WARD, CAPPELLETTI, MALONE, HUGHES, COMITTA, KANE, HUTCHINSON, HAYWOOD AND VOGEL, SEPTEMBER 4, 2025 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, SEPTEMBER 4, 2025 A RESOLUTIONDesignating the month of September 2025 as "Childhood Cancer Awareness Month" in Pennsylvania.WHEREAS, Childhood cancer is the second leading cause of death in children under 15 years of age, exceeded only by car accidents; andWHEREAS, The American Cancer Society estimates that approximately 9,550 children in the United States under 15 years of age will be diagnosed with cancer in 2025, continuing the trend of year-over-year decreases with the figure standing at 9,610 in 2024; andWHEREAS, According to the American Cancer Society, approximately 1,050 children (age 0 to 14) are expected to die from cancer in 2025; andWHEREAS, In August 2024, the Pennsylvania Health Care Cost Containment Council (PHC4) published a research brief providing insight into hospitalization rates and trends among Pennsylvania 12345678910111213141516 children from 2016 through 2023; andWHEREAS, According to PHC4, hospitalizations due to a pediatric cancer diagnosis ranged from a high of 3,051 hospitalizations in 2019 and a low of 2,555 hospitalizations in 2022; andWHEREAS, Leukemia, secondary cancers (metastatic) and cancers involving bone, connective tissue and skin, respectively, were the three most prevalent amongst those hospitalized; andWHEREAS, The potential years of life lost to childhood cancer and the potential years of life saved by treatment exceed all other cancers with the exception of breast cancer; andWHEREAS, Most children cannot be treated at a local hospital and families must face the disruption of relocating to receive treatment at a regional cancer center; andWHEREAS, As a result of major treatment advances in recent decades, more than 85% of children with cancer now survive five years or more; andWHEREAS, The survival rate of children with cancer has significantly increased since the mid-1970s, when the five-year survival rate was approximately 58%; andWHEREAS, Survival rates vary depending on the type of cancer and other factors; andWHEREAS, Due to children's bodies still growing and cancer treatments largely geared toward use on adults, children are more likely to experience long-term side effects from treatment; andWHEREAS, Possible late effects of cancer treatments include, but are not limited to, heart or lung problems, slowed or delayed development, changes in sexual development and the ability to have children, learning disabilities and increased 20250SR0140PN1129 - 2 - 123456789101112131415161718192021222324252627282930 risk of secondary forms of cancer; andWHEREAS, Childhood cancer treatment is handled by a team of pediatric oncologists, pediatric surgeons, radiation oncologists, pediatric oncology nurses, nurse practitioners and physician assistants; andWHEREAS, Other members of the team of health professionals aiding in the health and well-being of childhood cancer patients include, but are not limited to, psychologists, social workers, child life specialists, nutritionists, rehabilitation and physical therapists and educators; andWHEREAS, Some of the most important members of a pediatric cancer patient's team are experienced parents who navigate and advocate on behalf of their children; andWHEREAS, This Commonwealth is a leader in the fight against and treatment of childhood cancer with seven Children's Oncology Group hospitals: Children's Hospital of Philadelphia, Penn State Health Children's Hospital, UPMC Children's Hospital of Pittsburgh, Penn Medicine's Abramson Cancer Center, Geisinger Medical Center's Janet Weis Children's Hospital, Tower Health's St. Christopher's Hospital for Children and Lehigh Valley's Reilly Children's Hospital; andWHEREAS, Several of the institutions participate in national consortiums committed to bringing clinicians, scientists, philanthropy and families together to enhance and facilitate trial development to advance pediatric cancer treatments and long-term care; andWHEREAS, The Commonwealth has invested in telepresence educational equipment that childhood cancer patients utilize to allow for greater remote learning opportunities during long absences and to increase access to needed social supports; and20250SR0140PN1129 - 3 - 123456789101112131415161718192021222324252627282930 WHEREAS, Act 39 of 2017 allowed for donations to the Pediatric Cancer Research Fund (PCRF) to be used for pediatric cancer research funded by reductions in personal income tax refunds; andWHEREAS, Act 73 of 2018 allowed for an additional funding stream for the PCRF via electronic driver's license, registration and identification card renewals; andWHEREAS, As of July 2025, the PCRF collected $4,508,463.92; andWHEREAS, Beginning with fiscal year 2021-2022 through fiscal year 2024-2025, the Commonwealth has earmarked approximately $40 million from the Tobacco Master Settlement Agreement to be allocated to pediatric cancer research; therefore be itRESOLVED, That the Senate designate the month of September 2025 as "Childhood Cancer Awareness Month" in Pennsylvania; and be it furtherRESOLVED, That the Senate and all related organizations continue their efforts in aiding children battling pediatric cancer while simultaneously renewing its commitment to the cause; and be it furtherRESOLVED, That the Senate encourage young Pennsylvanians who are fighting cancer, honor young people who have lost their lives to childhood cancer, express gratitude to the doctors, nurses and parents who provide special care to patients and families affected by childhood cancer and encourage all residents in this Commonwealth to join the fight against childhood cancer.20250SR0140PN1129 - 4 - 123456789101112131415161718192021222324252627


================================================================================

Raw Text:
2025-2026 Regular Session SR 140 PN 1129 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1129 THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE RESOLUTION No.140 Session of 2025 INTRODUCED BY MARTIN, BROWN, SCHWANK, LAUGHLIN, PHILLIPS-HILL, ROBINSON, MASTRIANO, ARGALL, BOSCOLA, TARTAGLIONE, CULVER, BROOKS, FONTANA, J. WARD, CAPPELLETTI, MALONE, HUGHES, COMITTA, KANE, HUTCHINSON, HAYWOOD AND VOGEL, SEPTEMBER 4, 2025 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, SEPTEMBER 4, 2025 A RESOLUTIONDesignating the month of September 2025 as "Childhood Cancer Awareness Month" in Pennsylvania.WHEREAS, Childhood cancer is the second leading cause of death in children under 15 years of age, exceeded only by car accidents; andWHEREAS, The American Cancer Society estimates that approximately 9,550 children in the United States under 15 years of age will be diagnosed with cancer in 2025, continuing the trend of year-over-year decreases with the figure standing at 9,610 in 2024; andWHEREAS, According to the American Cancer Society, approximately 1,050 children (age 0 to 14) are expected to die from cancer in 2025; andWHEREAS, In August 2024, the Pennsylvania Health Care Cost Containment Council (PHC4) published a research brief providing insight into hospitalization rates and trends among Pennsylvania 12345678910111213141516 children from 2016 through 2023; andWHEREAS, According to PHC4, hospitalizations due to a pediatric cancer diagnosis ranged from a high of 3,051 hospitalizations in 2019 and a low of 2,555 hospitalizations in 2022; andWHEREAS, Leukemia, secondary cancers (metastatic) and cancers involving bone, connective tissue and skin, respectively, were the three most prevalent amongst those hospitalized; andWHEREAS, The potential years of life lost to childhood cancer and the potential years of life saved by treatment exceed all other cancers with the exception of breast cancer; andWHEREAS, Most children cannot be treated at a local hospital and families must face the disruption of relocating to receive treatment at a regional cancer center; andWHEREAS, As a result of major treatment advances in recent decades, more than 85% of children with cancer now survive five years or more; andWHEREAS, The survival rate of children with cancer has significantly increased since the mid-1970s, when the five-year survival rate was approximately 58%; andWHEREAS, Survival rates vary depending on the type of cancer and other factors; andWHEREAS, Due to children's bodies still growing and cancer treatments largely geared toward use on adults, children are more likely to experience long-term side effects from treatment; andWHEREAS, Possible late effects of cancer treatments include, but are not limited to, heart or lung problems, slowed or delayed development, changes in sexual development and the ability to have children, learning disabilities and increased 20250SR0140PN1129 - 2 - 123456789101112131415161718192021222324252627282930 risk of secondary forms of cancer; andWHEREAS, Childhood cancer treatment is handled by a team of pediatric oncologists, pediatric surgeons, radiation oncologists, pediatric oncology nurses, nurse practitioners and physician assistants; andWHEREAS, Other members of the team of health professionals aiding in the health and well-being of childhood cancer patients include, but are not limited to, psychologists, social workers, child life specialists, nutritionists, rehabilitation and physical therapists and educators; andWHEREAS, Some of the most important members of a pediatric cancer patient's team are experienced parents who navigate and advocate on behalf of their children; andWHEREAS, This Commonwealth is a leader in the fight against and treatment of childhood cancer with seven Children's Oncology Group hospitals: Children's Hospital of Philadelphia, Penn State Health Children's Hospital, UPMC Children's Hospital of Pittsburgh, Penn Medicine's Abramson Cancer Center, Geisinger Medical Center's Janet Weis Children's Hospital, Tower Health's St. Christopher's Hospital for Children and Lehigh Valley's Reilly Children's Hospital; andWHEREAS, Several of the institutions participate in national consortiums committed to bringing clinicians, scientists, philanthropy and families together to enhance and facilitate trial development to advance pediatric cancer treatments and long-term care; andWHEREAS, The Commonwealth has invested in telepresence educational equipment that childhood cancer patients utilize to allow for greater remote learning opportunities during long absences and to increase access to needed social supports; and20250SR0140PN1129 - 3 - 123456789101112131415161718192021222324252627282930 WHEREAS, Act 39 of 2017 allowed for donations to the Pediatric Cancer Research Fund (PCRF) to be used for pediatric cancer research funded by reductions in personal income tax refunds; andWHEREAS, Act 73 of 2018 allowed for an additional funding stream for the PCRF via electronic driver's license, registration and identification card renewals; andWHEREAS, As of July 2025, the PCRF collected $4,508,463.92; andWHEREAS, Beginning with fiscal year 2021-2022 through fiscal year 2024-2025, the Commonwealth has earmarked approximately $40 million from the Tobacco Master Settlement Agreement to be allocated to pediatric cancer research; therefore be itRESOLVED, That the Senate designate the month of September 2025 as "Childhood Cancer Awareness Month" in Pennsylvania; and be it furtherRESOLVED, That the Senate and all related organizations continue their efforts in aiding children battling pediatric cancer while simultaneously renewing its commitment to the cause; and be it furtherRESOLVED, That the Senate encourage young Pennsylvanians who are fighting cancer, honor young people who have lost their lives to childhood cancer, express gratitude to the doctors, nurses and parents who provide special care to patients and families affected by childhood cancer and encourage all residents in this Commonwealth to join the fight against childhood cancer.20250SR0140PN1129 - 4 - 123456789101112131415161718192021222324252627